undamentalytics Newsletter
Sign in

Geovax Labs, Inc. balance sheet

At the end of fiscal 2025, Geovax Labs, Inc. had total assets of $6.3m, total liabilities of $2.5m and shareholders' equity of $3.8m. It held $3.1m in cash against $0 of debt: net cash of $3.1m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents00001011286633
Receivables———————010—
Total current assets10101012298854
Total assets10101012319865
Accounts payable00000223212
Total current liabilities01221554323
Long-term debt——0000—————
Total debt00000000000
Total liabilities—122175—333
Shareholders' equity0−0−1−2104276542
Net debt (negative = net cash)−0−00−0−10−11−28−6−6−3−3
Shares outstanding————12m—————7m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Geovax Labs, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Geovax Labs, Inc.